On December 19, 2025, Arcadia Biosciences, Inc. held its annual stockholder meeting where significant decisions were made including the election of directors, approval of executive compensation, and ratification of Deloitte & Touche LLP as their accountants. Approximately 51% of shares were present, with key votes resulting in the election of three directors and the approval of compensation with 72,445 votes in favor and 70,865 against.